Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

Description

The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).

Conditions

Postoperative Urinary Retention (POUR)

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).

Peri-operative Tamsulosin and Impact on Voiding Trial Following Outpatient Urogynecology Surgery: a Randomized Controlled Trial

Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

Condition
Postoperative Urinary Retention (POUR)
Intervention / Treatment

-

Contacts and Locations

Cincinnati

TriHealth, Cincinnati, Ohio, United States, 45220

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Any surgery involving a non-urogynecologist
  • * Patients already on an alpha blocker
  • * Baseline hypotension
  • * History of syncope
  • * Postural orthostatic tachycardia syndrome (POTS)
  • * Non-English speaker or interpreter unavailable for Spanish-speaking patient
  • * Impaired cognition impeding proper consenting
  • * Any other medical contraindication for tamsulosin use
  • * History of urinary retention requiring continuous or intermittent catheterization
  • * Patients consented for the study but then due to intraoperative complication, routine voiding trial no longer indicated due to requiring indwelling catheter or intermittent catheterization on discharge will be excluded from primary outcome analysis
  • * Pregnancy

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

TriHealth Inc.,

Study Record Dates

2026-06-01